Oragenics Prices Offering Of Common Stock At $2.50 Each

(RTTNews) - Healthcare company Oragenics Inc. (OGEN) Friday priced an underwritten public offering of 4.4 million shares of its common stock at a public offering price of $2.50 per share for aggregate proceeds of $11 million, prior to underwriting discounts and offering expenses.

The offering is expected to close on or about November 20 2013, subject to satisfaction of customary closing conditions.

Oragenics engages in the development of technologies associated with oral health, antibiotics, and other general health benefits.

The company's stock is trading at $2.65, down $0.15 or 5.36%, on the NYSE.